Luke Clauson,Tsontcho Ianchulev,Nathan White,Richard S. Lilly,Matthew Newell,Michael Schaller
申请号：
US14260041
公开号：
US20140323995A1
申请日:
2014.04.23
申请国别(地区):
US
年份:
2014
代理人:
摘要：
This disclosure relates generally to methods and devices for use in treating eye conditions. In some embodiments, a site-specific therapeutic agent is mixed with a releasing agent with a dual syringe apparatus in order to achieve homogeneity. Once mixed, the site-specific therapeutic agent and releasing agent can be either dispensed directly within an area of the eye or within an implant. The implant can be at least partially filled with the site-specific therapeutic agent and releasing agent either prior to or after implantation into the eye. Some ratios of site-specific therapeutic agents to releasing agents are disclosed which provide various releasing profiles of the site-specific therapeutic agent within the eye.
